21 C.F.R. § 601.93

Postmarketing safety reporting.

Last amended: 2016Year: 2026Length: 21 wordsOfficial source

Cite as 21 C.F.R. § 601.93 (2026)

Biological products approved under this subpart are subject to the postmarketing recordkeeping and safety reporting applicable to all approved biological products.
21 C.F.R. § 601.93: Postmarketing safety reporting. | Justis AI